Glycopyrronium News
Glycopyrronium currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Glycopyrronium with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Bevespi Aerosphere is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
- Evidence level: L5
- Predicted indications (20):
- irritable bowel syndrome (98.8%)
- cauda equina syndrome (98.5%)
- obsolete neurogenic bladder (disease) (97.7%)
- neurocirculatory asthenia (96.9%)
- migraine disorder (96.1%)
- migraine with brainstem aura (95.7%)
- open-angle glaucoma (95.6%)
- autonomic nervous system disease (95.5%)
- primary hereditary glaucoma (95.3%)
- dysthymic disorder (93.7%)
- common cold (93.3%)
- dysautonomia (92.5%)
- headache disorder (90.9%)
- familial mitral valve prolapse (90.5%)
- mitral valve prolapse (disease) (90.5%)
- insomnia (disease) (89.7%)
- MVP1 (89.5%)
- multiple system atrophy (89.3%)
- trigeminal autonomic cephalalgia (89.2%)
- atrophoderma vermiculata (88.8%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.